Navigation Links
Philadelphia scientists to be honored with the John Scott Award
Date:10/20/2011

October 20, 2011 -Philadelphia, Pa Two internationally recognized scientists with strong Philadelphia ties are to receive the John Scott Award this year. The award ceremony will be held at 5:30 p.m. on Friday, November 4, 2011 in the Ashhurst Room of The College of Physicians of Philadelphia, located at 19 South 22nd Street.

The John Scott Award award is named after a Scottish chemist and philanthropist who had a love of Philadelphia and deep admiration for Ben Franklin. It is given to the "most deserving" men and women whose inventions have contributed in some outstanding way to the "comfort, welfare and happiness" of mankind. Nominations of individuals for the award are made by a committee of Philadelphians to the Board of Directors of City Trusts of the City of Philadelphia.

This year, the John Scott Award goes to Jenny Pickworth Glusker, D.Sc. and David E. Kuhl, MD. Both scientists are credited with scientific discoveries that opened up a whole new way of examining cellular metabolism in the human body. Each recipient's research led to their two separate, dramatic scientific breakthroughs of the late 20th century.

Dr. Glusker contributed to the discovery of the chemical formula for Vitamin B12. This important milestone in chemistry unlocked the shape of this largest molecule at the time, and, ultimately, the clues to how it works. Today, B12 is an essential water-soluble vitamin that is commonly found in a variety of foods and human cells. Vitamin B12 deficiency is also commonly found in the elderly. "I just did what chemists love to do find out how and why things work," said Jenny Glusker, D. Sc. Her career began in her native England where she studied and worked at University of Oxford. She then went on to work at the California Institute of Technology before landing in Philadelphia at Fox Chase Cancer Center where she has since spent the last 50 years. Her work in cancer research has included the determination of the structure
'/>"/>

Contact: Diana Quattrone
Diana.Quattrone@fccc.edu
215-728-7784
Fox Chase Cancer Center
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Grant funds science career days for Philadelphia public school students
2. Rare Pennsylvania fungus is named for Philadelphia botanist
3. Epilepsy researcher at the Childrens Hospital of Philadelphia receives scientific prize
4. Gene links to anorexia found by Childrens Hospital of Philadelphia researchers
5. Childrens Hospital of Philadelphia collaborates in gene therapy success in an immune disorder
6. AACR hosts cancer prevention meeting in Philadelphia
7. Bird book with ties to Philadelphia natural history museum wins international award
8. Two Central High (Philadelphia) grads honored by AIBS
9. American Society for Microbiology to host 109th general meeting in Philadelphia
10. The American Society of Human Genetics hosts 58th Annual Meeting in Philadelphia
11. 46 outstanding life scientists elected to EMBO membership
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/2/2015)... , April 2, 2015 ... tests DERMALOG by far outperforms the strongest competitors, ... maintaining high accuracy, the system is capable of ... the speed proves up to be ten times ... than its runner-up performance.      (Photo: ...
(Date:4/2/2015)... , April 2, 2015 ... Q1 2015 attributed to somewhat higher than 125 MSEK. ... the year-end report 2014 that revenues for Q1 2015 ... the company reported for Q4 2014. The operating result ... be negative. The complete interim report will as previously ...
(Date:4/1/2015)... , Apr. 1, 2015  NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce market, ... Wocket smart wallets is underway to early access pre-order ... group includes usage at retail outlets including Walmart, Target, ... Users report Wocket was accepted at all outlets and ...
Breaking Biology News(10 mins):DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3Fingerprint Cards Revises Revenues for Q1 2015 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 4
... are often touted as one method to help decrease society,s addiction ... to be done before fuel cells will be ready for mass ... for emergencies. U of C chemists Jeff Hurd and George ... cell towards a higher level of design. They have discovered a ...
... Scientists are developing new scaffolding technology which could ... and cartilage using 3D spaghetti-like structures. Their research is ... highlights magazine of the Biotechnology and Biological Sciences Research ... by scientists from the University of Bristol, using proteins ...
... clinical-stage biopharmaceutical company developing a new class of drugs ... data from its recently completed Phase 2b clinical trial ... with major depressive disorder, or MDD, who did not ... citalopram hydrobromide. In the trial, the add-on TC-5214 ...
Cached Biology News:U of C chemists discover recipe to design a better type of fuel cell 2'Spaghetti' scaffolding could help grow skin in labs 2Targacept's P.2b depression study succeeds: 6-point difference on HAM-D 2Targacept's P.2b depression study succeeds: 6-point difference on HAM-D 3
(Date:4/21/2015)... , April 21, 2015 Invetech ... development, custom automation, and contract manufacturing, and  NanoCellect ... flow cytometry and cell sorting technology for life ... a novel flow cytometry platform. Headquartered ... Biomedical has developed a microchip-based cell sorting technology. ...
(Date:4/21/2015)... , April 21, 2015  scPharmaceuticals, Inc., ... pharmaceutical products for subcutaneous delivery, announced today ... of its investigational proprietary drug product, Furosemide ... associated with congestive heart failure. ... developing a proprietary patch pump.  The patch ...
(Date:4/21/2015)... Cleveleys (UK) (PRWEB) April 21, 2015 ... technology and its clinical applications will be ... Participants include engineers, scientists, regulators and clinicians ... The meeting is sponsored by Invibio Biomaterial ... polymer-based biomaterials, a specialist in manufacturing and ...
(Date:4/20/2015)... and MENLO PARK, Calif. ... Inc. (OTCQX: DMPI) (DelMar and the Company), ... proven cancer therapies in new orphan drug indications, ... 106th Annual Meeting of the American Association for ... potential for its lead product candidate VAL-083 ...
Breaking Biology Technology:NanoCellect And Invetech Announce Collaboration To Develop Novel Flow Cytometry Platform For Cell Sorting And Analysis 2NanoCellect And Invetech Announce Collaboration To Develop Novel Flow Cytometry Platform For Cell Sorting And Analysis 3scPharmaceuticals Announces Start of Pivotal Trial for Novel Furosemide Solution for Subcutaneous Delivery 2scPharmaceuticals Announces Start of Pivotal Trial for Novel Furosemide Solution for Subcutaneous Delivery 32nd International PEEK Meeting: Invibio Biomaterial Solutions spearheads medical research for implantable PEEK polymer devices 22nd International PEEK Meeting: Invibio Biomaterial Solutions spearheads medical research for implantable PEEK polymer devices 3DelMar Pharmaceuticals Presents Promising Preclinical Data on VAL-083's Potential to Treat Temozolomide-Resistant Glioblastoma Multiforme (GBM) 2DelMar Pharmaceuticals Presents Promising Preclinical Data on VAL-083's Potential to Treat Temozolomide-Resistant Glioblastoma Multiforme (GBM) 3DelMar Pharmaceuticals Presents Promising Preclinical Data on VAL-083's Potential to Treat Temozolomide-Resistant Glioblastoma Multiforme (GBM) 4DelMar Pharmaceuticals Presents Promising Preclinical Data on VAL-083's Potential to Treat Temozolomide-Resistant Glioblastoma Multiforme (GBM) 5
... will hold the $14 million clinical training programs administrative ... of Wisconsin-Madison intends to train more clinical researchers, whose ... science, with the help of a $14 million, five-year ... , ,Molly Carnes, a professor with appointments in the ...
... UW-Stout gets USDA grant for manufacturing training ETC announces ... in third quarter QRG Bioscience to move to Research ... , Home Health United signs deal with SBC ... a three-year deal with communications firm SBC . SBC will implement ...
... 21st Century Act, commonly called Check 21, two Wisconsin ... imaging. , ,Check 21, which will come into effect ... of the payments system by legalizing the use of ... documents. Using the substitute check, banks are permitted to ...
Cached Biology Technology:$14 million grant to drive clinical research at UW 2Tech Digest: whats moving in the Midwest 2Tech Digest: whats moving in the Midwest 3Wisconsin firms make acquisitions for Check 21 readiness 2
... AP Conjugate Stabilizer is an aqueous ... protein and other non-toxic stabilizing chemicals ... pH 5.5 6.5. This ... methylisothiazolone and 0.02% bromonitrodioxane as a ...
MAb to Myoglobin Cardiac...
... binding is a problem in your ... immobilized NeutrAvidin products as superior alternatives ... a modified avidin derivative that combines ... biotin-binding protein with exceptionally low nonspecific ...
Request Info...
Biology Products: